Literature DB >> 12032780

Transcription factor fusions in acute leukemia: variations on a theme.

Joseph M Scandura1, Piernicola Boccuni, Jorg Cammenga, Stephen D Nimer.   

Abstract

The leukemia-associated fusion proteins share several structural or functional similarities, suggesting that they may impart a leukemic phenotype through common modes of transcriptional dysregulation. The fusion proteins generated by these translocations usually contain a DNA-binding domain, domains responsible for homo- or hetero-dimerization, and domains that interact with proteins involved in chromatin remodeling (e.g., co-repressor molecules or co-activator molecules). It is these shared features that constitute the 'variations on the theme' that underling the aberrant growth and differentiation that is the hallmark of acute leukemia cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032780     DOI: 10.1038/sj.onc.1205315

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  Advances in the molecular genetics of acute leukemia.

Authors:  Joseph M Scandura
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

2.  The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3.

Authors:  Luke F Peterson; Anita Boyapati; Velvizhi Ranganathan; Atsushi Iwama; Daniel G Tenen; Schickwann Tsai; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.

Authors:  James C Mulloy; Vladimir Jankovic; Mark Wunderlich; Ruud Delwel; Jorg Cammenga; Ondrej Krejci; Hui Zhao; Peter J M Valk; Bob Lowenberg; Stephen D Nimer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-24       Impact factor: 11.205

Review 4.  Gene expression regulation and cancer.

Authors:  M Dolore Delgado; Javier León
Journal:  Clin Transl Oncol       Date:  2006-11       Impact factor: 3.405

Review 5.  Molecular mechanisms of leukemia-associated protein degradation.

Authors:  Ying-Li Wu; Hu-Chen Zhou; Guo-Qiang Chen
Journal:  Front Med China       Date:  2010-11-19

6.  Nup98-homeodomain fusions interact with endogenous Nup98 during interphase and localize to kinetochores and chromosome arms during mitosis.

Authors:  Songli Xu; Maureen A Powers
Journal:  Mol Biol Cell       Date:  2010-03-17       Impact factor: 4.138

Review 7.  Chromatin-modifying enzymes as therapeutic targets--Part 1.

Authors:  Brian R Keppler; Trevor K Archer
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

8.  Epigenetic consequences of AML1-ETO action at the human c-FMS locus.

Authors:  George A Follows; Hiromi Tagoh; Pascal Lefevre; Donald Hodge; Gareth J Morgan; Constanze Bonifer
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 9.  Clinical implications of molecular markers in acute myeloid leukemia.

Authors:  Sabine Kayser; Mark J Levis
Journal:  Eur J Haematol       Date:  2018-10-23       Impact factor: 2.997

10.  Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia.

Authors:  Kyung-Ok Uhm; Eun Soo Lee; Yun Mi Lee; Jeong Seon Park; Seok Jin Kim; Byung Soo Kim; Hyeon Soo Kim; Sun-Hwa Park
Journal:  J Korean Med Sci       Date:  2009-06-18       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.